NO179489C - Ekspresjonskassett, plasmid inneholdende ekspresjonskassetten, transformert gjærcelle og fremgangsmåte til fremstilling av en hirudinvariant - Google Patents

Ekspresjonskassett, plasmid inneholdende ekspresjonskassetten, transformert gjærcelle og fremgangsmåte til fremstilling av en hirudinvariant

Info

Publication number
NO179489C
NO179489C NO872878A NO872878A NO179489C NO 179489 C NO179489 C NO 179489C NO 872878 A NO872878 A NO 872878A NO 872878 A NO872878 A NO 872878A NO 179489 C NO179489 C NO 179489C
Authority
NO
Norway
Prior art keywords
gene
expression cassette
producing
yeast cell
plasmid containing
Prior art date
Application number
NO872878A
Other languages
English (en)
Norwegian (no)
Other versions
NO872878L (no
NO179489B (no
NO872878D0 (no
Inventor
Gerard Loison
Yves Lemoine
Nathalie Labat
Alain Balland
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR868610090A external-priority patent/FR2601383B2/fr
Priority claimed from FR868616722A external-priority patent/FR2607516B2/fr
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of NO872878D0 publication Critical patent/NO872878D0/no
Publication of NO872878L publication Critical patent/NO872878L/no
Publication of NO179489B publication Critical patent/NO179489B/no
Publication of NO179489C publication Critical patent/NO179489C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO872878A 1986-07-10 1987-07-10 Ekspresjonskassett, plasmid inneholdende ekspresjonskassetten, transformert gjærcelle og fremgangsmåte til fremstilling av en hirudinvariant NO179489C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR868610090A FR2601383B2 (fr) 1985-05-02 1986-07-10 Vecteurs perfectionnes d'expression de l'hirudine dans les levures, procede et produit obtenu
FR868616722A FR2607516B2 (fr) 1986-12-01 1986-12-01 Vecteurs perfectionnes d'expression d'un variant de l'hirudine dans les levures, procede et produit obtenu

Publications (4)

Publication Number Publication Date
NO872878D0 NO872878D0 (no) 1987-07-10
NO872878L NO872878L (no) 1988-01-11
NO179489B NO179489B (no) 1996-07-08
NO179489C true NO179489C (no) 1996-10-16

Family

ID=26225387

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872878A NO179489C (no) 1986-07-10 1987-07-10 Ekspresjonskassett, plasmid inneholdende ekspresjonskassetten, transformert gjærcelle og fremgangsmåte til fremstilling av en hirudinvariant

Country Status (20)

Country Link
US (2) US5591640A (de)
EP (1) EP0252854B1 (de)
JP (1) JP2733602B2 (de)
KR (1) KR960013464B1 (de)
AT (1) ATE153066T1 (de)
AU (1) AU614933B2 (de)
BG (1) BG80504A (de)
CA (1) CA1341490C (de)
CZ (1) CZ278268B6 (de)
DE (1) DE3752063T2 (de)
DK (1) DK175195B1 (de)
ES (1) ES2103700T3 (de)
FI (1) FI96966C (de)
GR (1) GR3024368T3 (de)
HU (1) HU214236B (de)
MC (1) MC1834A1 (de)
NO (1) NO179489C (de)
PL (1) PL154118B1 (de)
PT (1) PT85296B (de)
RU (1) RU1776276C (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
GB8809860D0 (en) * 1988-04-26 1988-06-02 Ciba Geigy Ag Process for production of polypeptides
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
FR2645175B1 (fr) * 1989-03-31 1994-02-18 Transgene Sa Souche de saccharomyces cerevisiaeproductrice d'une proteine heterologue et procede de preparation de ladite proteine heterologue par fermentation de ladite souche
FR2645174B1 (fr) * 1989-03-31 1994-01-07 Transgene Sa Souches de levure ameliorees pour la production de proteines heterologues matures en particulier d'hirudine et procede de preparation d'hirudine correspondant
US5879926A (en) * 1989-03-31 1999-03-09 Transgene S.A. Yeast strains for the production of mature heterologous proteins, especially hirudin
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
GB9015825D0 (en) * 1990-07-18 1990-09-05 Ciba Geigy Ag In vitro processing of fusion proteins
US6514730B1 (en) 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
SG49859A1 (en) * 1992-09-04 2002-03-19 Ucp Gen Pharma Ag Process for the production of protease inhibitors
TW282490B (de) * 1992-12-15 1996-08-01 Ciba Geigy Ag
US5712114A (en) * 1995-06-06 1998-01-27 Basf Aktiengesellschaft Compositions for expression of proteins in host cells using a preprocollagen signal sequence
KR20010034305A (ko) 1998-01-23 2001-04-25 한센 핀 베네드 효모에서 원하는 폴리펩티드를 만드는 방법
KR100949722B1 (ko) 2002-08-12 2010-03-25 에이펙셀 (주) 마이크로 초미립 분쇄기
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
US4769326A (en) * 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
NO840200L (no) * 1983-01-28 1984-07-30 Cefus Corp Glukoamylase cdna.
JPS6041487A (ja) * 1983-04-25 1985-03-05 ジエネンテツク・インコ−ポレイテツド 酵母発現系でのアルフア因子配列の使用
CA1341414C (fr) * 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
EP0168342B1 (de) * 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
FR2593518B1 (fr) * 1985-05-02 1989-09-08 Transgene Sa Vecteurs d'expression et de secretion de l'hirudine par les levures transformees
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.
MC1834A1 (fr) * 1986-07-10 1988-06-03 Transgene Sa Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation

Also Published As

Publication number Publication date
KR880007727A (ko) 1988-08-29
US5591640A (en) 1997-01-07
EP0252854B1 (de) 1997-05-14
CZ278268B6 (en) 1993-11-17
RU1776276C (ru) 1992-11-15
DK355887A (da) 1988-01-11
JP2733602B2 (ja) 1998-03-30
NO872878L (no) 1988-01-11
PL266756A1 (en) 1988-06-23
PL154118B1 (en) 1991-07-31
PT85296A (pt) 1988-07-29
NO179489B (no) 1996-07-08
MC1834A1 (fr) 1988-06-03
US5902735A (en) 1999-05-11
KR960013464B1 (ko) 1996-10-05
PT85296B (pt) 1995-05-31
ATE153066T1 (de) 1997-05-15
AU7536687A (en) 1988-01-14
BG80504A (bg) 1993-12-24
DE3752063D1 (de) 1997-06-19
EP0252854A1 (de) 1988-01-13
GR3024368T3 (en) 1997-11-28
CA1341490C (fr) 2005-08-30
FI873068A0 (fi) 1987-07-10
FI873068A (fi) 1988-01-11
HUT44616A (en) 1988-03-28
JPS6485082A (en) 1989-03-30
AU614933B2 (en) 1991-09-19
DK355887D0 (da) 1987-07-09
FI96966C (fi) 1996-09-25
CZ527787A3 (en) 1993-08-11
ES2103700T3 (es) 1997-10-01
DE3752063T2 (de) 1997-12-04
HU214236B (hu) 1998-03-02
DK175195B1 (da) 2004-07-05
FI96966B (fi) 1996-06-14
NO872878D0 (no) 1987-07-10

Similar Documents

Publication Publication Date Title
NO179489C (no) Ekspresjonskassett, plasmid inneholdende ekspresjonskassetten, transformert gjærcelle og fremgangsmåte til fremstilling av en hirudinvariant
ES2053648T3 (es) Proceso de ampliacion de un acido nucleico.
FI865303A (fi) Expressionsvektorer av hirudin och utsoendring av hirudin ur transformerad jaest.
ATE547532T1 (de) Verfahren zur erzeugung von hochgradig diversen bibliotheken
DE59611362D1 (de) Pflanzen, die eine modifizierte stärke synthetisieren, verfahren zu ihrer herstellung sowie modifizierte stärke
GR3033895T3 (en) Selective restriction fragment amplification : a general method for DNA fingerprinting.
DE69231745D1 (de) Gensequenzen kodierend für Flavonoid-Stoffwechselwegenzyme und deren Verwendung
DE69333491D1 (en) Protease-resistente analoge des thrombomodulin
PT83968A (de) Verfahren zur verbesserung des expression von eukaryontenprotein
CA2264967A1 (en) Method of dna sequencing
GR75145B (de)
ES8205429A1 (es) Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de fibro- blastos humanos.
ATE103329T1 (de) Verfahren zur herstellung von hgiairestriktionsendonuklease und -methylase.
ATE118816T1 (de) Verfahren zur herstellung von acci- restriktionsendonuklease und -methylase.
UA19039A (uk) Спосіб одержаhhя еритропоетиhу людиhи
ATE127154T1 (de) Verfahren zur herstellung der afl ii restriktionsendonuklease.
ES2057164T3 (es) Fragmentos de acido nucleico especificos del gen de la vilina humana y su utilizacion con fines diagnosticos.
FR2682376B1 (fr) Reactif utile pour le clivage et procede d'utilisation de ce reactif d'un groupe protecteur.
TH4461EX (th) การเตรียมเอนไซม์อีลาสเทส i จากตับอ่อนของคน
HUT40619A (en) Process for producing hydrazide of 3,4,5-trimethoxy-benzoic acid

Legal Events

Date Code Title Description
MK1K Patent expired